BioCentury | May 31, 2018
Product R&D

Lilly’s new leaf

...of a portfolio re-prioritization. The VC formed AurKa as a newco that year via its TVM Life Science Ventures...
BioCentury | May 18, 2018
Company News

Lilly continues to build cancer pipeline with AurKa acquisition

...toxicology studies, sold it to TVM Capital Life Science, which then formed AurKa through the TVM Life Science Ventures...
BioCentury | May 14, 2018
Company News

Lilly continues to build cancer pipeline with AurKa acquisition

...toxicology studies, sold it to TVM Capital Life Science, which then formed AurKa through the TVM Life Science Ventures...
BioCentury | Dec 9, 2016
Financial News

Ixchelsis completes venture financing

...Ixchelsis raised $12 million in venture financing from Pfizer Venture Investments and TVM Life Science Ventures VII fund. Ixchelsis...
BioCentury | Sep 26, 2016
Financial News

AurKa completes venture financing

...Montreal, Quebec Business: Cancer Date completed: 2016-09-19 Type: Venture financing Raised: $14.5 million Investor: TVM Life Science Ventures WIR...
BioCentury | Jul 11, 2016
Financial News

Argos completes private placement of common stock and warrants

...offering: 29.9 million Investors: Pharmstandard International S.A.; Forargos B.V.; Chongqing Lummy Pharmaceutical Co. Ltd. ; TVM Life Science Ventures...
BioCentury | Jun 27, 2016
Financial News

Mediti Pharma completes venture financing

...Montreal, Quebec Business: Neurology Date completed: 2016-06-20 Type: Venture financing Raised: Not disclosed Investor: TVM Life Science Ventures...
BioCentury | May 16, 2016
Financial News

Acer Therapeutics completes venture financing

...Cambridge, Mass. Business: Endocrine/Metabolic Date completed: 2016-05-09 Type: Venture financing Raised: $8.2 million Investors: TVM Life Science Ventures...
BioCentury | Apr 25, 2016
Finance

LPs choose Europe

...Europe. The others include funds managed by Domain Associates, Sanderling Ventures , Sectoral Asset Management, TVM Life Science Ventures...
BioCentury | Mar 14, 2016
Financial News

Argos completes private placement of common stock and warrants

...offering: 24.4 million Investors: Pharmstandard International S.A.; Forargos B.V.; Chongqing Lummy Pharmaceutical Co. Ltd. ; TVM Life Science Ventures...
Items per page:
1 - 10 of 39
BioCentury | May 31, 2018
Product R&D

Lilly’s new leaf

...of a portfolio re-prioritization. The VC formed AurKa as a newco that year via its TVM Life Science Ventures...
BioCentury | May 18, 2018
Company News

Lilly continues to build cancer pipeline with AurKa acquisition

...toxicology studies, sold it to TVM Capital Life Science, which then formed AurKa through the TVM Life Science Ventures...
BioCentury | May 14, 2018
Company News

Lilly continues to build cancer pipeline with AurKa acquisition

...toxicology studies, sold it to TVM Capital Life Science, which then formed AurKa through the TVM Life Science Ventures...
BioCentury | Dec 9, 2016
Financial News

Ixchelsis completes venture financing

...Ixchelsis raised $12 million in venture financing from Pfizer Venture Investments and TVM Life Science Ventures VII fund. Ixchelsis...
BioCentury | Sep 26, 2016
Financial News

AurKa completes venture financing

...Montreal, Quebec Business: Cancer Date completed: 2016-09-19 Type: Venture financing Raised: $14.5 million Investor: TVM Life Science Ventures WIR...
BioCentury | Jul 11, 2016
Financial News

Argos completes private placement of common stock and warrants

...offering: 29.9 million Investors: Pharmstandard International S.A.; Forargos B.V.; Chongqing Lummy Pharmaceutical Co. Ltd. ; TVM Life Science Ventures...
BioCentury | Jun 27, 2016
Financial News

Mediti Pharma completes venture financing

...Montreal, Quebec Business: Neurology Date completed: 2016-06-20 Type: Venture financing Raised: Not disclosed Investor: TVM Life Science Ventures...
BioCentury | May 16, 2016
Financial News

Acer Therapeutics completes venture financing

...Cambridge, Mass. Business: Endocrine/Metabolic Date completed: 2016-05-09 Type: Venture financing Raised: $8.2 million Investors: TVM Life Science Ventures...
BioCentury | Apr 25, 2016
Finance

LPs choose Europe

...Europe. The others include funds managed by Domain Associates, Sanderling Ventures , Sectoral Asset Management, TVM Life Science Ventures...
BioCentury | Mar 14, 2016
Financial News

Argos completes private placement of common stock and warrants

...offering: 24.4 million Investors: Pharmstandard International S.A.; Forargos B.V.; Chongqing Lummy Pharmaceutical Co. Ltd. ; TVM Life Science Ventures...
Items per page:
1 - 10 of 39